Breaking News

UBM Appoints Group Director

By Kristin Brooks | January 10, 2014

Kilbee to head strategic development of event brands

Chris Kilbee has been appointed group director of UBM Pharma Portfolio CPhI, part of UBM Live. Mr. Kilbee will be responsible for the strategic development and delivery of event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, China, India, Japan, Russia, Turkey, South America and South-East Asia, and digital solutions including CPhI Online and CPhI Pharma Evolution.
Mr. Kilbee is an experienced business leader who has worked across a number of different areas at UBM, most recently running a media and events business based in London. Chris has overseen the launch of CPhI Istanbul, a new event starting in 2014, and the completion of the company’s first Annual Industry Report.
Mr. Kilbee said, “I am delighted to be taking on this position and overseeing the Pharma portfolio at UBM Live. It is our vision to widen CPhI’s pharma portfolio across new and diverse geographies and platforms where we see opportunities emerging, delivering new services that help to connect the pharma community.”
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision